|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.30 INR | -0.58% |
|
-5.07% | -46.93% |
| Market Cap | 1.81B 18.76M 16.48M 15.32M 14.06M 26.42M 26.83M 182M 71.09M 888M 70.43M 68.91M 3.07B | P/E 2024 |
137x | P/E 2025 | -4.53x |
|---|---|---|---|---|---|
| Enterprise Value | 7.43B 77.15M 67.76M 63.01M 57.82M 109M 110M 748M 292M 3.65B 290M 283M 12.63B | EV / Sales 2024 |
0.77x | EV / Sales 2025 | 0.64x |
| Free-Float |
44.34% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.58% | ||
| 1 week | -5.07% | ||
| Current month | -10.98% | ||
| 1 month | -10.75% | ||
| 3 months | -12.64% | ||
| 6 months | -29.55% | ||
| Current year | -46.93% |
| 1 week | 10.21 | 11.03 | |
| 1 month | 10.21 | 11.99 | |
| Current year | 9.3 | 20.9 | |
| 1 year | 9.3 | 22.4 | |
| 3 years | 9.3 | 56.5 | |
| 5 years | 9.3 | 56.5 | |
| 10 years | 7.1 | 56.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sushil Kapoor
DFI | Director of Finance/CFO | 68 | 13/11/2022 |
| Compliance Officer | - | 31/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Sanjiv Goyal
CHM | Chairman | 66 | 26/06/1995 |
Rupinder Tewari
BRD | Director/Board Member | 69 | 10/02/2019 |
| Director/Board Member | 75 | 20/09/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/12/24 | Buy | 400,000 | 0.1784% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.58% | -5.07% | -40.15% | -51.87% | 20.78M | ||
| -0.66% | +0.44% | +14.72% | +76.40% | 48.36B | ||
| +2.20% | +1.41% | +61.04% | +111.43% | 35.8B | ||
| +1.26% | -0.57% | -5.20% | +34.48% | 11.83B | ||
| -0.46% | -3.06% | +14.15% | +80.63% | 11.48B | ||
| -0.37% | -0.37% | +37.89% | +137.78% | 9.01B | ||
| +1.52% | +0.39% | +48.79% | -5.82% | 6.99B | ||
| -0.17% | -2.92% | +13.13% | +30.45% | 6.7B | ||
| -0.59% | -1.95% | +2.23% | +178.07% | 6.42B | ||
| -7.92% | -13.61% | -34.97% | -4.08% | 5.3B | ||
| Average | -0.58% | -2.41% | +11.16% | +58.75% | 14.19B | |
| Weighted average by Cap. | +0.12% | -0.45% | +25.34% | +81.34% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 16.85B 175M 154M 143M 131M 246M 250M 1.7B 663M 8.28B 657M 643M 28.63B | 16.7B 173M 152M 142M 130M 244M 248M 1.68B 657M 8.21B 651M 637M 28.39B |
| Net income | 49.95M 519K 456K 424K 389K 730K 742K 5.03M 1.97M 24.56M 1.95M 1.91M 84.91M | -1.14B -11.8M -10.37M -9.64M -8.85M -16.62M -16.88M -114M -44.73M -559M -44.32M -43.36M -1.93B |
| Net Debt | 6.15B 63.89M 56.11M 52.18M 47.88M 89.97M 91.36M 620M 242M 3.02B 240M 235M 10.46B | 5.62B 58.39M 51.28M 47.69M 43.76M 82.23M 83.49M 566M 221M 2.76B 219M 214M 9.56B |
Employees
1,786
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | ₹10.30 | -0.58% | 73,731 |
| 23/07/26 | ₹10.36 | -1.80% | 76,356 |
| 22/07/26 | ₹10.55 | -1.40% | 84,687 |
| 21/07/26 | ₹10.70 | -0.93% | 71,281 |
| 20/07/26 | ₹10.80 | -0.46% | 70,264 |
- Stock Market
- Stocks
- NECLIFE Stock
Select your edition
All financial news and data tailored to specific country editions
















